The Claim
In older adults undergoing exercise training, once-weekly administration of sirolimus at 6 mg is associated with small, non-significant trends toward reduced grip strength and walking distance compared to placebo, indicating a potential broad attenuation of functional adaptations that extends beyond lower-body strength improvements.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Older adults who take a weekly 6 mg dose of sirolimus while exercising might see slightly less improvement in hand strength and walking ability compared to those taking a fake pill — suggesting the drug could be limiting some of the usual benefits of exercise.
See the scientific wording
In older adults, once-weekly sirolimus 6 mg during exercise training is associated with small, non-significant trends toward reduced grip strength and walking distance compared to placebo, suggesting a possible broad attenuation of functional adaptations beyond lower-body strength.
What the research says
1 studyThe study found that older adults taking weekly sirolimus while exercising had slightly worse grip strength and walking distance than those on placebo, but the differences weren’t strong enough to rule out chance. This matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.